These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10632404)

  • 1. GnRH antagonists.
    Devroey P
    Fertil Steril; 2000 Jan; 73(1):15-7. PubMed ID: 10632404
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of gonadotropin-releasing hormone antagonists in in vitro fertilization.
    Diedrich K; Ludwig M; Felberbaum RE
    Semin Reprod Med; 2001 Sep; 19(3):213-20. PubMed ID: 11679902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix.
    Bahceci M; Ulug U; Tosun S; Erden HF; Bayazit N
    Fertil Steril; 2006 May; 85(5):1523-5. PubMed ID: 16566935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of gonadotropin-releasing hormone antagonist in ovarian stimulation.
    Olivennes F
    Clin Obstet Gynecol; 2006 Mar; 49(1):12-22. PubMed ID: 16456339
    [No Abstract]   [Full Text] [Related]  

  • 5. Gonadotrophin-releasing hormone antagonists for assisted conception.
    Al-Inany H; Aboulghar M
    Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone antagonist: new tools vs. old habits.
    Bouchard P; Fauser BC
    Fertil Steril; 2000 Jan; 73(1):18-20. PubMed ID: 10632405
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for in vitro fertilization.
    Orvieto R; Laufer N
    Fertil Steril; 2014 Nov; 102(5):1254-5. PubMed ID: 25282471
    [No Abstract]   [Full Text] [Related]  

  • 8. Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization.
    Kolibianakis EM; Zikopoulos K; Smitz J; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    Fertil Steril; 2004 Jul; 82(1):223-6. PubMed ID: 15237018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GnRH antagonists in IVF].
    Olivennes F; Fanchin R; Lédée N; Righini C; Bouchard P; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(7 Pt 1):657-62; discussion 662-3. PubMed ID: 11917361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol.
    Griesinger G; Dawson A; Schultze-Mosgau A; Finas D; Diedrich K; Felberbaum R
    Fertil Steril; 2006 Mar; 85(3):791-3. PubMed ID: 16500366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone (GnRH) analogues and the ovary: do GnRH antagonists destroy primordial follicles?
    Gupta RK; Flaws JA
    Fertil Steril; 2005 May; 83(5):1339-42. PubMed ID: 15866566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Perspectives in the use of GnRh antagonists].
    Olivennes F; Rongières C; Fanchin R; Frydman R
    Contracept Fertil Sex; 1998 Mar; 26(3):187-8. PubMed ID: 9592965
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
    Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle.
    Kummer NE; Weitzman VN; Benadiva CA; Schmidt DW; Engmann LL; Nulsen JC
    Fertil Steril; 2011 Jun; 95(8):2592-4. PubMed ID: 21292260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor.
    Mannaerts B; Gordon K
    Hum Reprod; 2000 Sep; 15(9):1882-3. PubMed ID: 10966979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cetrorelix lowers premature luteinization rate in gonadotropin ovulation induction-intrauterine insemination cycles: a randomized-controlled clinical trial.
    Steward RG; Gill I; Williams DB; Witz CA; Griffith J; Haddad GF
    Fertil Steril; 2011 Jan; 95(1):434-6. PubMed ID: 20810107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GnRH antagonists and mild ovarian stimulation for intrauterine insemination: a randomized study comparing different gonadotrophin dosages.
    Ragni G; Alagna F; Brigante C; Riccaboni A; Colombo M; Somigliana E; Crosignani PG
    Hum Reprod; 2004 Jan; 19(1):54-8. PubMed ID: 14688156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GnRH antagonist (Orgalutran) for prevention of premature LH surges during controlled ovarian hyperstimulation].
    Vladimirov Ia
    Akush Ginekol (Sofiia); 2001; 40(4):21-6. PubMed ID: 11803865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.